Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivoPeibin Yue, James Turkson, Simoun Mikhael et al.|Cancer Letters|2022Cited by 21
Azetidine ring, salicylic acid, and salicylic acid bioisosteres as determinants of the binding characteristics of novel potent compounds to Stat3Yue Chen, James Turkson, Ning Zhai et al.|Bioorganic & Medicinal Chemistry Letters|2023Cited by 5
Abstract 514: Novel potent azetidine-based inhibitors bind irreversibly to Stat3 DNA-binding domain (DBD) and are efficacious against tumor growth in miceYue Chen, James Turkson, Ning Zhai et al.|Cancer Research|2023Cited by 0
Azetidine Ring, Salicylic Acid, and Salicylic Acid Bioisosteres as Determinants of the Binding Characteristics of Novel Potent Compounds to Stat3Yue Chen, James Turkson, Yinsong Zhu et al.|SSRN Electronic Journal|2023Cited by 0
Abstract 663: Irreversible covalent azetidine-based small molecule inhibitors of Stat3 activity block growth of human pancreatic tumorsYue Chen, James Turkson, Ning Zhai et al.|Cancer Research|2024Cited by 0